Loading...

QUANTUSRT-OCT

HIGH PRECISION IMAGE DIAGNOSIS

Diagnostic aid in Diabetic Retinopathy

PERSONALIZED CLINICAL SERVICE

OUR TEST OFFERS SAFETY AND ACCURACY WITHOUT BEING INVASIVE.

WEB SERVICES RESTFUL

Compatible HL7 FHIR
logo

About us

quantusRT-OCT® is a non-invasive, fast, reliable and easy-to-use test for the automatic detection of pathological markers corresponding to microcysts and hyperreflective spots in diabetic retinopathy. The images used will be optical coherence tomography (OCT).

quantusRT-OCT® has been designed as a tool to help clinicians, especially by giving an automatic assessment of the quantitative analysis of different retinal slices of the eye obtained by an ocular tomography.

By simply analyzing and classifying optical coherence tomography (OCT) scans, quantusRT-OCT® determines the number of slices from the 15-30 images that make up an OCT study, which are predicted to be positive, within minutes.

Personalized Medicine

quantusRT-OCT is presented as a web application easy to use by specialists that allows them to upload images captured through a tomograph, which performs certain retinal slices, to analyze automatically and receive reliable results in a few minutes.

Advantages of QuantusRT-OCT

Non invasive

Our test is non-invasive, it is performed from a set of images.

Reliable

quantusRT-OCT is a test that indicates the number of slices with microcysts or hyper-reflective spots out of the 15-30 images that make up an OCT study.

Fast

You will receive the result in a matter of minutes.

HL7

COMPATIBLE HL7

quantusRT-OCT supports the HL7 FHIR protocol through its REST services.

The physician uploads an image to the platform and, in a few minutes, quantusRT-OCT indicates the number of slices with microcysts or hyper-reflective spots out of the 15-30 images that make up an OCT study.

The test includes:
- The analysis of the ocular tomography.
- The result report in electronic format.

The test does not include:
- The doctor's consultation (ask the doctor about the possible cost)
- Other complementary tests

quantusRT-OCT has been designed with a clear focus on the diabetic population and is intended to be a screening tool for diabetic retinopathies, being of great help in the screening of patients at risk, the follow-up of patients and the prioritization of waiting lists.

Therefore, anyone can take the test at any time.

You can discuss with your doctor the existence of quantusRT-OCT and if you want to take the test you can go to one of the referenced centers where they will give you a report that you can then send to your doctor to be included in your medical record.

If your doctor wants to have more information about quantusRT-OCT and wants to try it, he/she only has to consult the web page www.quantusRT-OCT.org. where he/she will have all the clinical information.

We have professionals at your disposal who will guide you and tell you which clinic you should go to for your test. Contact us by e-mail at info@transmuralbiotech.com or by phone at 931190229 and 626667989.